AbL Diagnostics SA (ABLD) - Total Liabilities

Latest as of June 2025: €4.17 Million EUR ≈ $4.88 Million USD

Based on the latest financial reports, AbL Diagnostics SA (ABLD) has total liabilities worth €4.17 Million EUR (≈ $4.88 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore AbL Diagnostics SA operating cash flow efficiency to assess how effectively this company generates cash.

AbL Diagnostics SA - Total Liabilities Trend (2007–2024)

This chart illustrates how AbL Diagnostics SA's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of AbL Diagnostics SA to evaluate the company's liquid asset resilience ratio.

AbL Diagnostics SA Competitors by Total Liabilities

The table below lists competitors of AbL Diagnostics SA ranked by their total liabilities.

Company	Country	Total Liabilities
Foresta Group Holdings Ltd AU:FGH	Australia	AU$2.89 Million
Vrancart Adjud RO:VNC	Romania	RON477.89 Million
DESWELL INDS INC. DL-01 F:DW2	Germany	€20.17 Million
Gokul Refoils and Solvent Limited NSE:GOKUL	India	Rs5.51 Billion
Elsoft Research Bhd KLSE:0090	Malaysia	RM5.75 Million
KL-Net Corp KQ:039420	Korea	₩7.27 Billion
Arrow Syndicate Public Company Limited BK:ARROW	Thailand	฿390.27 Million
Wonik Cube Corp KQ:014190	Korea	₩37.20 Billion

Liability Composition Analysis (2007–2024)

This chart breaks down AbL Diagnostics SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ABLD market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.26	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.60	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.38	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how AbL Diagnostics SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for AbL Diagnostics SA (2007–2024)

The table below shows the annual total liabilities of AbL Diagnostics SA from 2007 to 2024.

Year	Total Liabilities	Change
2024-12-31	€4.32 Million ≈ $5.05 Million	-46.86%
2023-12-31	€8.14 Million ≈ $9.51 Million	-5.99%
2022-12-31	€8.65 Million ≈ $10.12 Million	+9081.14%
2021-12-31	€94.26K ≈ $110.20K	+420.78%
2020-12-31	€18.10K ≈ $21.16K	-84.70%
2019-12-31	€118.31K ≈ $138.32K	-80.07%
2018-12-31	€593.64K ≈ $694.03K	+346.04%
2017-12-31	€133.09K ≈ $155.60K	-17.93%
2016-12-31	€162.18K ≈ $189.60K	-79.83%
2015-12-31	€804.11K ≈ $940.09K	+460.64%
2014-12-31	€143.43K ≈ $167.68K	-34.43%
2013-12-31	€218.75K ≈ $255.74K	+151.83%
2012-12-31	€86.86K ≈ $101.55K	-21.84%
2011-12-31	€111.14K ≈ $129.94K	+2.38%
2010-12-31	€108.56K ≈ $126.91K	+90.10%
2009-12-31	€57.10K ≈ $66.76K	+12.32%
2008-12-31	€50.84K ≈ $59.44K	-1.20%
2007-12-31	€51.46K ≈ $60.16K	--

About AbL Diagnostics SA

PA:ABLD France Health Information Services

Market Cap

$45.49 Million

€38.91 Million EUR

Market Cap Rank

#22487 Global

#357 in France

Share Price

€2.42

Change (1 day)

+2.54%

52-Week Range

€2.36 - €5.65

All Time High

€16.08